ELIGIBILITY for Pharmaceutical Benefits Scheme (PBS) access to COVID-19 oral antiviral treatments, has been widened from today.
Under the new criteria, First Nations people aged 30 years and older with one risk factor, rather than two, can now access Lagevrio or Paxlovid through the PBS.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Nov 22
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Nov 22
